All In MedTech

FDA Clearance Tracker · P070008-S107

Corox OTW BP

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 4, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 4, 2019

Approved

Time to decision

35 days

Received Aug 30, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P070008-S107
Device name
Corox OTW BP
Applicant location
Lake Oswego, OR
Received
Aug 30, 2019
Decided
Oct 4, 2019
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P070008

Device type

Device class
Class III

Every decision under product code NKE

FDA's approval statement

As written in FDA's record.

Approval for labeling updates to the clinical study summary for the post approval study.

Source documents

Other decisions for Biotronik, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.